ProCE Banner Activity

Racial Disparities in COVID-19: Causes, Consequences, and Clinical Strategies

Video

What accounts for racial disparities in COVID-19 outcomes? Hear expert insights on the healthcare inequities affecting patients who are Black, indigenous, or people of color and learn about strategies for overcoming barriers to optimal COVID-19 care.

Released: October 28, 2021

Expiration: October 27, 2022

No longer available for credit.

Share

Faculty

Oni Blackstock

Oni Blackstock, MD, MHS

Founder & Executive Director
Health Justice
New York, New York

Nina T. Harawa

Nina T. Harawa, PhD, MPH

Professor of Medicine and Epidemiology
Department of Medicine and Psychiatry
UCLA David Geffen School of Medicine
Charles R. Drew University of Medicine and Science
Los Angeles, California

David Malebranche

David Malebranche, MD, MPH

Internal Medicine Physician
HIV/Sexual Health Specialist
AIDS Healthcare Foundation (AHF) Medical Clinic
Atlanta, Georgia

Stephaun Elite Wallace

Stephaun Elite Wallace, PhD, MS

Staff Scientist
Director of External Relations
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center
Clinical Assistant Professor
Global Health
University of Washington
Seattle, Washington

Supporters

Gilead Sciences, Inc.

Partners

BAI

ProCE Banner

IAS 2021

ProCE Banner

Faculty Disclosure

Primary Author

Oni Blackstock, MD, MHS

Founder & Executive Director
Health Justice
New York, New York

Oni Blackstock, MD, MHS, has no relevant conflicts of interest to report.

Nina T. Harawa, PhD, MPH

Professor of Medicine and Epidemiology
Department of Medicine and Psychiatry
UCLA David Geffen School of Medicine
Charles R. Drew University of Medicine and Science
Los Angeles, California

Nina T. Harawa, PhD, MPH, has disclosed that she has received funds for research support and fees for non-CME/CE services from Gilead Sciences.

David Malebranche, MD, MPH

Internal Medicine Physician
HIV/Sexual Health Specialist
AIDS Healthcare Foundation (AHF) Medical Clinic
Atlanta, Georgia

David Malebranche, MD, MPH, has disclosed that he has received consulting fees from Gilead Sciences and ViiV Healthcare and funds for non-CME/CE services from Gilead Sciences.

Stephaun Elite Wallace, PhD, MS

Staff Scientist
Director of External Relations
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center
Clinical Assistant Professor
Global Health
University of Washington
Seattle, Washington

Stephaun E. Wallace, PhD, MS, has disclosed that he has received consulting fees from ViiV Healthcare and funds for research support from Johnson & Johnson/Janssen.